What is Beijing Science Sun Pharmaceutical Co., Ltd.'s (300485.SZ) StockRank?

MoatMap's StockRank for Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) is 27/100, with a Sell signal. This is a composite score combining Quality (57), Value (36), and Momentum (25) factor ranks across MoatMap's 20,000+ stock universe.

Does Beijing Science Sun Pharmaceutical Co., Ltd. have an economic moat?

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Beijing Science Sun Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Beijing Science Sun Pharmaceutical Co., Ltd. in?

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300485.SZ

SELLFLAG

Beijing Science Sun Pharmaceutical Co., Ltd. · Healthcare · China · $634M · Avg Vol: $7M/d

StockRank

P/E (TTM)

—

ROE

-0.8%

D/E

0.0x

Dividend %

3.5%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Beijing Science Sun has a respectable quality score of 56 and operates in biochemical manufacturing. While it has potential CDMO-adjacent capabilities, it lacks the global scale and validated regulatory moat of top-tier CDMOs.

COMPANY DESCRIPTION

Beijing Science Sun Pharmaceutical Co., Ltd. develops, manufactures, and markets biochemical and chemical pharmaceuticals, with a core focus on cardiovascular, cerebrovascular, and immunomodulatory therapies. The company's product portfolio includes specialized injections and active pharmaceutical ingredients (APIs). It maintains a stable niche market position in China through its established clinical distribution channels and targeted therapeutic focus.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	109M	70M	62M	60M	-18.0%
EPS	0.06	0.03	-0.02	0.00	-58.8%
Shares	482M	482M	482M	482M	0.0%
Debt	0	0	25M	3M	-88.1%
Equity	499M	508M	496M	498M	-0.0%
Op CF	16M	3M	20M	4M	-37.4%
Inv CF	5M	-13M	-26M	-7M	—
Fin CF	-12M	-6M	-870,112	3M	—

PRICE (1M)-24.4%

SMA 50SMA 200

$1.22

RSI (14)

38.9

52W High

$2.58

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

0.4%45.2

ROE

-0.8%43.8

GP/Assets

7.3%21.8

Op. Margin

10.5%67.5

FCF/Assets

-1.7%44.6

Piotroski

—55.7

Int. Cover

28.1x78.5

D/E Ratio

0.01x91.9

Current Ratio

20.09x95.6

Value

P/E (TTM)

—N/A

EV/EBITDA

65.2x5.0

P/FCF

—N/A

P/B

1.2x74.2

P/S

10.0x26.0

Div Yield

3.5%78.0

Momentum

52W High %

47%20.7

RS 6M

-35%33.8

SMA 50/200

0.90x34.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-88%2.5

FUNDAMENTALS

Market Cap

$634M

P/E (Forward)

—

Gross Margin

64.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300485.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300485.SZ	Beijing Science Sun Pharmaceutical Co., Ltd.(you)	$634M	27	SELL
002907.SZ	Chongqing Pharscin Pharmaceutical Co., Ltd.	$765M	26	SELL
002365.SZ	Qianjiang Yongan Pharmaceutical Co., Ltd.	$512M	28	SELL
002793.SZ	Luoxin Pharmaceuticals Group Stock Co., Ltd.	$690M	31	SELL
002728.SZ	Teyi Pharmaceutical Group Co.,Ltd	$671M	32	SELL
688621.SS	Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	$894M	26	SELL
300584.SZ	Nanjing Hicin Pharmaceutical Co., Ltd.	$612M	20	STRONG SELL
688247.SS	Sinotherapeutics Inc.	$571M	32	SELL
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.	$893M	28	SELL
301277.SZ	Newland Pharmaceutical Co., Ltd.	$574M	34	SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.0%

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) — Stock Score Summary

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) has a MoatMap StockRank of 27/100 based on Quality (57/100), Value (36/100), and Momentum (25/100) factor scores. The current signal is SELL. Beijing Science Sun has a respectable quality score of 56 and operates in biochemical manufacturing. While it has potential CDMO-adjacent capabilities, it lacks the global scale and validated regulatory moat of top-tier CDMOs.

Key Financial Metrics

Price	$1.22
Market Cap	$634M
Price/Book	1.19
Return on Equity	-0.8%
Return on Invested Capital	0.4%
Debt/Equity	0.58
Gross Margin	64.9%
Operating Margin	10.5%
Revenue Growth	-2.3%
Dividend Yield	3.5%
Free Cash Flow	$-1M

Beijing Science Sun Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Science Sun Pharmaceutical Co., Ltd.’s (300485.SZ) StockRank?: MoatMap’s StockRank for Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) is 27/100, with a Sell signal. It is a composite of Quality (57), Value (36), and Momentum (25) factor ranks across MoatMap’s 20,000+ stock universe.
Does Beijing Science Sun Pharmaceutical Co., Ltd. have an economic moat?: Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Science Sun Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Science Sun Pharmaceutical Co., Ltd. in?: Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).